Impact BioMedical, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $3.0K | $2.0M | $1.0K | $2.0K | — |
| Accounts Receivable | $5.0K | — | — | — | — |
| Inventory | $63.0K | — | — | — | — |
| Total Current Assets | $411.0K | $2.4M | $332.0K | $122.0K | — |
| Property, Plant & Equipment | — | $17.0K | $287.0K | $276.0K | — |
| Goodwill | — | — | $25.1M | $25.1M | — |
| Intangible Assets (Excl. Goodwill) | $17.0M | $17.8M | $18.9M | $20.0M | — |
| Total Assets | $17.4M | $20.3M | $44.6M | $46.5M | — |
| Liabilities | |||||
| Accounts Payable | $347.0K | $314.0K | $832.0K | $539.0K | — |
| Total Current Liabilities | $1.2M | $9.8M | $13.1M | $10.6M | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $1.9M | $13.1M | $16.4M | $13.8M | — |
| Stockholders' Equity | |||||
| Retained Earnings | $-49.5M | $-37.7M | $-13.0M | $-8.6M | — |
| Total Stockholders' Equity | $12.6M | $4.3M | $25.2M | $29.6M | $39.9M |